{
    "2021-07-12": [
        [
            {
                "time": "",
                "original_text": "扎堆上市 狂并购买连锁药店不缺资金缺管理",
                "features": {
                    "keywords": [
                        "扎堆上市",
                        "并购",
                        "连锁药店",
                        "资金",
                        "管理"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大参林今日大宗交易成交5.61万股，成交价42.21元折价9.21%",
                "features": {
                    "keywords": [
                        "大参林",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "大参林现1笔大宗交易 共成交236.80万元",
                "features": {
                    "keywords": [
                        "大参林",
                        "大宗交易"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：十三五开启血制品新成长周期 重点推荐天坛生物、博雅生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "十三五",
                        "血制品",
                        "成长周期",
                        "天坛生物",
                        "博雅生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}